Wilson Sonsini Goodrich & Rosati advised 858 Therapeutics on intellectual property matters related to the transaction.858 Therapeutics announced raising $50 million in a Series B financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
